Literature DB >> 10919368

Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa.

N Ohno1, N N Miura, M Nakajima, T Yadomae.   

Abstract

Sparassis crispa is an edible mushroom recently cultivable in Japan. Polysaccharide fractions were prepared from the cultured S. crispa by repeated extraction with hot water (SCHWE), cold NaOH (SCCA), and then hot NaOH (SCHA). HWE was further separated by 1 volume (SCHWE1v) or 4 volumes (SCHWE4v) of ethanol-precipitable fractions. By chemical, enzymic, and NMR analyses, the primary structures of SCHWE1v, SCCA, and SCHA were 6-branched 1,3-beta-glucan, having one branch in approximately every third mainchain unit. All of these fractions showed antitumor activity to the solid form of Sarcoma 180 in ICR mice with strong vascular dilation and hemorrhage reaction. These fractions also showed enhanced hematopoietic response to cyclophosphamide induced leukopenic mice following intraperitoneal or peroral administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919368     DOI: 10.1248/bpb.23.866

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  27 in total

1.  Sequence Analysis and Expression of a Blue-light Photoreceptor Gene, Slwc-1 from the Cauliflower Mushroom Sparassis latifolia.

Authors:  Chi Yang; Lu Ma; Zhenghe Ying; Xiaoling Jiang; Yanquan Lin
Journal:  Curr Microbiol       Date:  2017-02-22       Impact factor: 2.188

2.  Beneficial effect of Sparassis crispa on stroke through activation of Akt/eNOS pathway in brain of SHRSP.

Authors:  Hisae Yoshitomi; Emiko Iwaoka; Masahide Kubo; Masaru Shibata; Ming Gao
Journal:  J Nat Med       Date:  2010-11-13       Impact factor: 2.343

Review 3.  Medicinal, nutritional, and nutraceutical potential of Sparassis crispa s. lat.: a review.

Authors:  Neha Sharma; Ashwani Tapwal; Rachna Verma; Dinesh Kumar; Eugenie Nepovimova; Kamil Kuca
Journal:  IMA Fungus       Date:  2022-05-06       Impact factor: 8.044

Review 4.  Antiinflammatory and immunomodulating properties of fungal metabolites.

Authors:  Cristina Lull; Harry J Wichers; Huub F J Savelkoul
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

5.  Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP).

Authors:  Tze-chen Hsieh; Peili Wu; Spencer Park; Joseph M Wu
Journal:  BMC Complement Altern Med       Date:  2006-09-11       Impact factor: 3.659

6.  The pharmacological potential of mushrooms.

Authors:  Ulrike Lindequist; Timo H J Niedermeyer; Wolf-Dieter Jülich
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

7.  Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class.

Authors:  Marta Lemieszek; Wojciech Rzeski
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

Review 8.  Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa.

Authors:  Takashi Kimura
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

Review 9.  Immunostimulatory properties and antitumor activities of glucans (Review).

Authors:  Luca Vannucci; Jiri Krizan; Petr Sima; Dmitry Stakheev; Fabian Caja; Lenka Rajsiglova; Vratislav Horak; Mustafa Saieh
Journal:  Int J Oncol       Date:  2013-06-05       Impact factor: 5.650

10.  Generation and Evaluation of High β-Glucan Producing Mutant Strains of Sparassis crispa.

Authors:  Seung-Rak Kim; Hyeon-Woo Kang; Hyeon-Su Ro
Journal:  Mycobiology       Date:  2013-09-30       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.